New trends in cannabis potency in USA and Europe during the last decade (2008-2017)

Suman Chandra, Mohamed M Radwan, Chandrani G Majumdar, James C Church, Tom P Freeman, Mahmoud A ElSohly

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Through the potency monitoring program at the University of Mississippi supported by National Institute on Drug Abuse (NIDA), a total of 18108 samples of cannabis preparations have been analyzed over the last decade, using a validated GC/FID method. The samples are classified as sinsemilla, marijuana, ditchweed, hashish, and hash oil (now referred to as cannabis concentrate). The number of samples received over the last 5 years has decreased dramatically due to the legalization of marijuana either for medical or for recreational purposes in many US states. The results showed that the mean Δ9-THC concentration has increased dramatically over the last 10 years, from 8.9% in 2008 to 17.1% in 2017. The mean Δ9-THC:CBD ratio also rose substantially from 23 in 2008 to 104 in 2017. There was also marked increase in the proportion of hash oil samples (concentrates) seized (0.5-4.7%) and their mean Δ9-THC concentration (6.7-55.7%) from 2008 to 2017. Other potency monitoring programs are also present in several European countries such as The Netherlands, United Kingdom, France, and Italy. These programs have also documented increases in Δ9-THC concentrations and Δ9-THC:CBD ratios in cannabis. These trends in the last decade suggest that cannabis is becoming an increasingly harmful product in the USA and Europe.

Original languageEnglish
Pages (from-to)5-15
Number of pages11
JournalEuropean Archives of Psychiatry and Clinical Neuroscience
Volume269
Issue number1
Early online date22 Jan 2019
DOIs
Publication statusPublished - 1 Feb 2019

Keywords

  • CBD
  • CBG
  • CBN
  • Cannabis
  • Concentrates
  • Hash oil
  • Hashish
  • Marijunna
  • Potency monitoring
  • Sinsemilla
  • Δ -THC

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Pharmacology (medical)

Cite this

New trends in cannabis potency in USA and Europe during the last decade (2008-2017). / Chandra, Suman; Radwan, Mohamed M; Majumdar, Chandrani G; Church, James C; Freeman, Tom P; ElSohly, Mahmoud A.

In: European Archives of Psychiatry and Clinical Neuroscience, Vol. 269, No. 1, 01.02.2019, p. 5-15.

Research output: Contribution to journalArticle

Chandra, Suman ; Radwan, Mohamed M ; Majumdar, Chandrani G ; Church, James C ; Freeman, Tom P ; ElSohly, Mahmoud A. / New trends in cannabis potency in USA and Europe during the last decade (2008-2017). In: European Archives of Psychiatry and Clinical Neuroscience. 2019 ; Vol. 269, No. 1. pp. 5-15.
@article{a064b8c7c3d44d3cae2e3737a2c715b7,
title = "New trends in cannabis potency in USA and Europe during the last decade (2008-2017)",
abstract = "Through the potency monitoring program at the University of Mississippi supported by National Institute on Drug Abuse (NIDA), a total of 18108 samples of cannabis preparations have been analyzed over the last decade, using a validated GC/FID method. The samples are classified as sinsemilla, marijuana, ditchweed, hashish, and hash oil (now referred to as cannabis concentrate). The number of samples received over the last 5 years has decreased dramatically due to the legalization of marijuana either for medical or for recreational purposes in many US states. The results showed that the mean Δ9-THC concentration has increased dramatically over the last 10 years, from 8.9{\%} in 2008 to 17.1{\%} in 2017. The mean Δ9-THC:CBD ratio also rose substantially from 23 in 2008 to 104 in 2017. There was also marked increase in the proportion of hash oil samples (concentrates) seized (0.5-4.7{\%}) and their mean Δ9-THC concentration (6.7-55.7{\%}) from 2008 to 2017. Other potency monitoring programs are also present in several European countries such as The Netherlands, United Kingdom, France, and Italy. These programs have also documented increases in Δ9-THC concentrations and Δ9-THC:CBD ratios in cannabis. These trends in the last decade suggest that cannabis is becoming an increasingly harmful product in the USA and Europe.",
keywords = "CBD, CBG, CBN, Cannabis, Concentrates, Hash oil, Hashish, Marijunna, Potency monitoring, Sinsemilla, Δ -THC",
author = "Suman Chandra and Radwan, {Mohamed M} and Majumdar, {Chandrani G} and Church, {James C} and Freeman, {Tom P} and ElSohly, {Mahmoud A}",
year = "2019",
month = "2",
day = "1",
doi = "10.1007/s00406-019-00983-5",
language = "English",
volume = "269",
pages = "5--15",
journal = "European Archives of Psychiatry and Clinical Neuroscience",
issn = "0940-1334",
publisher = "Springer",
number = "1",

}

TY - JOUR

T1 - New trends in cannabis potency in USA and Europe during the last decade (2008-2017)

AU - Chandra, Suman

AU - Radwan, Mohamed M

AU - Majumdar, Chandrani G

AU - Church, James C

AU - Freeman, Tom P

AU - ElSohly, Mahmoud A

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Through the potency monitoring program at the University of Mississippi supported by National Institute on Drug Abuse (NIDA), a total of 18108 samples of cannabis preparations have been analyzed over the last decade, using a validated GC/FID method. The samples are classified as sinsemilla, marijuana, ditchweed, hashish, and hash oil (now referred to as cannabis concentrate). The number of samples received over the last 5 years has decreased dramatically due to the legalization of marijuana either for medical or for recreational purposes in many US states. The results showed that the mean Δ9-THC concentration has increased dramatically over the last 10 years, from 8.9% in 2008 to 17.1% in 2017. The mean Δ9-THC:CBD ratio also rose substantially from 23 in 2008 to 104 in 2017. There was also marked increase in the proportion of hash oil samples (concentrates) seized (0.5-4.7%) and their mean Δ9-THC concentration (6.7-55.7%) from 2008 to 2017. Other potency monitoring programs are also present in several European countries such as The Netherlands, United Kingdom, France, and Italy. These programs have also documented increases in Δ9-THC concentrations and Δ9-THC:CBD ratios in cannabis. These trends in the last decade suggest that cannabis is becoming an increasingly harmful product in the USA and Europe.

AB - Through the potency monitoring program at the University of Mississippi supported by National Institute on Drug Abuse (NIDA), a total of 18108 samples of cannabis preparations have been analyzed over the last decade, using a validated GC/FID method. The samples are classified as sinsemilla, marijuana, ditchweed, hashish, and hash oil (now referred to as cannabis concentrate). The number of samples received over the last 5 years has decreased dramatically due to the legalization of marijuana either for medical or for recreational purposes in many US states. The results showed that the mean Δ9-THC concentration has increased dramatically over the last 10 years, from 8.9% in 2008 to 17.1% in 2017. The mean Δ9-THC:CBD ratio also rose substantially from 23 in 2008 to 104 in 2017. There was also marked increase in the proportion of hash oil samples (concentrates) seized (0.5-4.7%) and their mean Δ9-THC concentration (6.7-55.7%) from 2008 to 2017. Other potency monitoring programs are also present in several European countries such as The Netherlands, United Kingdom, France, and Italy. These programs have also documented increases in Δ9-THC concentrations and Δ9-THC:CBD ratios in cannabis. These trends in the last decade suggest that cannabis is becoming an increasingly harmful product in the USA and Europe.

KW - CBD

KW - CBG

KW - CBN

KW - Cannabis

KW - Concentrates

KW - Hash oil

KW - Hashish

KW - Marijunna

KW - Potency monitoring

KW - Sinsemilla

KW - Δ -THC

UR - http://www.scopus.com/inward/record.url?scp=85060538381&partnerID=8YFLogxK

U2 - 10.1007/s00406-019-00983-5

DO - 10.1007/s00406-019-00983-5

M3 - Article

VL - 269

SP - 5

EP - 15

JO - European Archives of Psychiatry and Clinical Neuroscience

JF - European Archives of Psychiatry and Clinical Neuroscience

SN - 0940-1334

IS - 1

ER -